Clinical efficacy of 3 days versus 5 days of oral amoxicillin for treatment of childhood pneumonia: a multicentre double-blind trial
- 1 September 2002
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 360 (9336), 835-841
- https://doi.org/10.1016/s0140-6736(02)09994-4
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Short-course antimicrobial therapy for upper respiratory tract infectionsClinical Therapeutics, 2000
- Don't keep taking the tablets?The Lancet, 1999
- Antimicrobial resistance and clinical effectiveness of co-trimoxazole versus amoxycillin for pneumonia among children in Pakistan: randomised controlled trialThe Lancet, 1998
- Adherence to cotrimoxazole treatment for acute lower respiratory tract infections in rural Bangladeshi children.Paediatrics and International Child Health, 1998
- A short (3-day) course of azithromycin tablets versus a 10-day course of amoxycillin–clavulanic acid (co-amoxiclav) in the treatment of adults with lower respiratory tract infections and effects on long-term outcomeInternational Journal of Antimicrobial Agents, 1998
- AzithromycinDrugs, 1998
- Azithromycin: 3-Day Versus 5-Day Course in the Treatment of Respiratory Tract Infections in ChildrenJournal of Chemotherapy, 1997
- Azithromycin: the first of the tissue-selective azalidesInternational Journal of Antimicrobial Agents, 1995
- Meta-analysis of intervention trials on case-management of pneumonia in community settingsThe Lancet, 1992
- Double-blind randomized study comparing the efficacies and safeties of a short (3-day) course of azithromycin and a 5-day course of amoxicillin in patients with acute exacerbations of chronic bronchitisAntimicrobial Agents and Chemotherapy, 1992